Dare Bioscience, Inc. (DARE) Insider Trading Activity

NASDAQ$0.6802+0.03 (4.62%)
Market Cap
$9.74M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
507 of 849
Rank in Industry
293 of 491

DARE Insider Trading Activity

DARE Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Dare Bioscience, Inc.

Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual arousal disorder; DARE-HRT1 to treat vasomotor …

Insider Activity of Dare Bioscience, Inc.

Over the last 12 months, insiders at Dare Bioscience, Inc. have bought $0 and sold $0 worth of Dare Bioscience, Inc. stock.

On average, over the past 5 years, insiders at Dare Bioscience, Inc. have bought $0 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 454,545 shares for transaction amount of $500,000 was made by HAWLEY ROGER (director) on 2019‑04‑11.

List of Insider Buy and Sell Transactions, Dare Bioscience, Inc.

2019-04-11PurchaseHAWLEY ROGERdirector
454,545
2.8482%
$1.10
$500,000
-22.94%
2018-06-11PurchaseHAWLEY ROGERdirector
140,000
1.2031%
$1.45
$203,378
-35.81%
2016-02-22PurchaseWALT DAVID Rdirector
1,182
0.0043%
$2.09
$2,468
-32.54%
2016-02-19PurchaseWALT DAVID Rdirector
3,400
0.0125%
$2.08
$7,058
-27.67%
2016-02-18PurchaseWALT DAVID Rdirector
9,000
0.033%
$2.09
$18,802
-25.96%
2016-02-17PurchaseWALT DAVID Rdirector
8,920
0.0329%
$2.12
$18,882
-17.62%
2016-02-16PurchaseWALT DAVID Rdirector
9,000
0.0325%
$2.00
$18,028
-5.17%
2016-02-12PurchaseWALT DAVID Rdirector
8,622
0.0324%
$2.00
$17,263
+1.03%
2016-02-11PurchaseWALT DAVID Rdirector
8,700
0.0324%
$2.03
$17,665
-1.51%
2016-02-10PurchaseWALT DAVID Rdirector
9,000
0.0335%
$2.08
$18,679
-3.43%
2016-02-09PurchaseWALT DAVID Rdirector
9,000
0.0333%
$2.08
$18,697
-3.17%
2016-02-08PurchaseWALT DAVID Rdirector
9,000
0.0344%
$2.15
$19,318
-2.93%
2016-02-05PurchaseWALT DAVID Rdirector
9,000
0.033%
$2.29
$20,651
-11.79%
2016-02-04PurchaseWALT DAVID Rdirector
8,126
0.0294%
$2.31
$18,761
-13.09%
2016-02-03PurchaseWALT DAVID Rdirector
8,036
0.0294%
$2.27
$18,262
-10.57%
2016-02-02PurchaseWALT DAVID Rdirector
8,790
0.0331%
$2.37
$20,818
-11.30%
2016-02-01PurchaseWALT DAVID Rdirector
9,000
0.0329%
$2.37
$21,328
-13.50%
2016-01-29PurchaseWALT DAVID Rdirector
2,400
0.0088%
$2.40
$5,772
-14.17%
2016-01-28PurchaseWALT DAVID Rdirector
9,000
0.034%
$2.45
$22,036
-12.87%
2016-01-27PurchaseWALT DAVID Rdirector
9,000
0.0331%
$2.46
$22,132
-15.16%
Total: 49

Insider Historical Profitability

<0.0001%
Crane Alan L
4771739
31.8541%
$3.1M10
Polaris Venture Management Co. V, L.L.C.10 percent owner
3262437
21.7786%
$2.12M10
VENROCK ASSOCIATES V LP10 percent owner
3015017
20.1269%
$1.96M10
CVF, LLC10 percent owner
2592577
17.3069%
$1.69M20
LILLY ELI & CO10 percent owner
2356227
15.7292%
$1.53M10
Hall Steven Edward
2356227
15.7292%
$1.53M10
Lux Capital Management, LLC
951999
6.3551%
$618,799.3510
HAWLEY ROGERdirector
944956
6.3081%
$614,221.4020
<0.0001%
WALT DAVID Rdirector
167491
1.1181%
$108,869.15380
RASTETTER WILLIAM Hdirector
60307
0.4026%
$39,199.5510

Historical Insider Profitability vs. Competitors

$95,567,744
39
-17.01%
$10.94M
$30,257,839
29
-15.72%
$12M
$76,600
22
-38.58%
$10.49M
$555,628
21
43.52%
$12.04M
$37,200,153
21
-47.67%
$12.66M

DARE Institutional Investors: Active Positions

Increased Positions16+61.54%310,623+32.01%
Decreased Positions10-38.46%62,409-6.43%
New Positions11New131,976New
Sold Out Positions4Sold Out16,137Sold Out
Total Postitions32+23.08%1M+25.58%

DARE Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$770.002.82%394,897+66,569+20.27%2025-09-30
Amh Equity Ltd$453.001.66%232,373+38,770+20.03%2025-09-30
Geode Capital Management, Llc$241.000.88%123,373+27,918+29.25%2025-09-30
Susquehanna International Group, Llp$117.000.43%60,221-46,666-43.66%2025-09-30
Renaissance Technologies Llc$115.000.42%58,895-12,900-17.97%2025-09-30
State Street Corp$46.000.17%23,51500%2025-09-30
Ubs Group Ag$44.000.16%22,621+7,613+50.73%2025-09-30
Virtu Financial Llc$35.000.13%17,740+17,740New2025-09-30
Blackrock, Inc.$33.000.12%16,97100%2025-09-30
Raymond James Financial Inc$30.000.11%15,334+13,650+810.57%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.